HBI Deals+Insights / News
Pan-European private equity firm Astorg is acquiring American medical device maker Thermo Fisher Scientific’s microbiology business for around $1 billion. Astorg plans to run the business as a standalone platform, focusing on organic growth, selective M&A, and operational improvements.





